Stockscreener 앱 받기
4.43
4.73%
-0.22
Abeona Therapeutics Inc 주식(ABEO)의 최신 뉴스
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc.ABEO - GlobeNewswire Inc.
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Two new hires' awards cover up to 7,200 Abeona shares, which become theirs over three years if they stay. - Stock Titan
Form 4 Abeona Therapeutics Inc For: 29 September By Investing.com - Investing.com South Africa
Form 4 Abeona Therapeutics Inc For: 29 September By Investing.com - Investing.com Nigeria
Abeona Therapeutics CEO Seshadri sells $101,091 in shares By Investing.com - Investing.com South Africa
Abeona Therapeutics CEO Seshadri sells $101,091 in shares By Investing.com - Investing.com Nigeria
Abeona Therapeutics CFO Joseph Vazzano sells $47,385 in company stock - Investing.com
Abeona Therapeutics CEO Seshadri sells $101,091 in shares - Investing.com
Abeona Therapeutics CFO Joseph Vazzano sells $47,385 in company stock By Investing.com - Investing.com South Africa
Abeona Therapeutics SVP sells $34,681 in company stock By Investing.com - Investing.com South Africa
Abeona Therapeutics SVP sells $34,681 in company stock - Investing.com
Abeona Therapeutics CCO Madhav sells $25,272 in stock - Investing.com
Abeona Therapeutics CCO Madhav sells $25,272 in stock By Investing.com - Investing.com Canada
To cover stock-award taxes, Abeona Therapeutics (ABEO) CFO sells 9,191 shares. - Stock Titan
To cover stock-award taxes, Abeona Therapeutics (ABEO) legal chief sold 6,727 shares. - Stock Titan
To cover stock-award taxes, Abeona Therapeutics (ABEO) CEO sells 19,608 shares. - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc.ABEO - GlobeNewswire Inc.
To cover taxes on vested stock, an Abeona Therapeutics (ABEO) officer lists shares valued at $47,385 for sale. - Stock Titan
Tax coverage after share vesting: an Abeona Therapeutics (ABEO) officer lists 19,608 shares for sale. - Stock Titan
Tax-related share sale: Abeona Therapeutics (ABEO) lists an officer’s shares for sale at a $34,682 value - Stock Titan
Abeona Therapeutics (NasdaqCM:ABEO) Stock Forecast & Analyst Predictions - Simply Wall Street
Abeona Therapeutics (NASDAQ: ABEO) posts new deck for H.C. Wainwright conference - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc.ABEO - PR Newswire
Abeona at Cantor healthcare conference: slow launch, big rare-disease bet - Investing.com Canada
Abeona at Cantor healthcare conference: slow launch, big rare-disease bet - Investing.com
ABEO Investors Have Opportunity to Join Abeona Therapeutics Inc. Fraud Investigation with SBS Law - Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc.ABEO - FinancialContent
Don't Ignore The Insider Selling In Abeona Therapeutics - simplywall.st
Responsive Playbooks and the ABEO Inflection - Stock Traders Daily
Abeona Therapeutics director Mark Alvino sells $87,966 in shares By Investing.com - Investing.com Australia
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences - GlobeNewswire
Abeona Therapeutics director Mark Alvino sells $87,966 in shares By Investing.com - Investing.com Canada
Abeona Therapeutics director Mark Alvino sells $87,966 in shares By Investing.com - Investing.com Nigeria
Abeona Therapeutics director Mark Alvino sells $87,966 in shares By Investing.com - Investing.com India
Abeona Therapeutics director Mark Alvino sells $87,966 in shares - Investing.com
Abeona Therapeutics director Mark Alvino sells $87,966 in shares By Investing.com - Investing.com UK
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences - kdhnews.com
Director Mark Alvino Sells 15,000 Shares of Abeona Therapeutics Inc (ABEO) - GuruFocus
Abeona Therapeutics (ABEO) director sells 15,000 shares, still holds 62,065 - Stock Titan
Director plans Abeona (NASDAQ: ABEO) stock sale from equity awards - Stock Titan
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Stock Titan
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Abeona Therapeutics faces securities fraud prob... - Pluang
H.C. Wainwright Maintains Abeona Therapeutics(ABEO.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Abeona (ABEO) Stock: Gains 2.18% to Reach $6.09 in the Latest Reading; Range Check: the Supplied Trading Band Runs From $5.79 to $6.39 for the Current SessionCatalyst Driven Stocks - vinanet.vn
High Insider Ownership Growth Stocks To Watch In August 2026 - simplywall.st
Abeona’s (ABEO) Gene Therapy Launch Hits A Pivotal Reimbursement Milestone - Yahoo Finance
Abeona (ABEO) Latest Quarter: EPS Misses Its Estimate in the Latest Session; Market Reaction: The Market Price Declines 2.77% for the Current SessionRevenue Growth Outlook - vinanet.vn
Abeona (ABEO) Q2 2026 Earnings Call Transcript - AOL.com
4.22%
자본화:
|
볼륨(24시간):